Moloney Securities Asset Management LLC Sells 545 Shares of Danaher Co. (NYSE:DHR)

Moloney Securities Asset Management LLC cut its holdings in Danaher Co. (NYSE:DHR) by 32.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,115 shares of the conglomerate’s stock after selling 545 shares during the period. Moloney Securities Asset Management LLC’s holdings in Danaher were worth $256,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter valued at $27,000. Decker Retirement Planning Inc. bought a new position in Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher in the fourth quarter worth about $31,000. Finally, Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher in the third quarter valued at approximately $39,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $203.42 on Tuesday. The company has a market capitalization of $146.92 billion, a P/E ratio of 38.53, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a fifty-two week low of $203.00 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a 50 day moving average price of $232.72 and a two-hundred day moving average price of $251.61.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company posted $2.09 earnings per share. Analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher’s dividend payout ratio is presently 20.45%.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on DHR. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. TD Cowen increased their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Citigroup dropped their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Finally, StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.